Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain-imaging surrogate markers for detection and prevention of age-related memory loss.

Journal of molecular neuroscience : MN - 1 Jan 2000

Small Gary W

Abstract excerpt

Recent evidence points to the importance of neuropathological and cognitive changes preceding Alzheimer's disease (AD), and clinical trials have begun to focus on preventive treatments designed to slow age-related cognitive decline and delay the onset of AD in people with age-associated memory impairment (AAMI). Studying subjects with few deficits leads to diagnostic heterogeneity and a need for larger samples in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Apolipoproteins E
Share to Diagnostic Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Memory Disorders

Share to Neurofibrillary Tangles

Share to Plaque, Amyloid

Share to Predictive Value of Tests

Share to Tomography, Emission-Computed

Source

Identifiers

PMID: 12212776
DOI: 10.1007/s12031-002-0005-7

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain-imaging surrogate markers for detection and prevention of age-related memory loss.PMID 12212776Read ↗

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.Semantic proximity Read ↗

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Early detection of Alzheimer's disease using neuroimaging.Semantic proximity Read ↗

Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.Semantic proximity Read ↗

Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's diseaseSemantic proximity Read ↗

Neuroimaging for diagnosis of dementia.Semantic proximity Read ↗

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Semantic proximity Read ↗

Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.Semantic proximity Read ↗

Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.Semantic proximity Read ↗

Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.Semantic proximity Read ↗

Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.